Budigalimab Antibody
Budigalimab (ABBV-181) is a humanized anti-PD-1 monoclonal antibody with potential antitumor activity. It is utilized in non-small cell lung cancer research, supporting both in vitro immune checkpoint blockade studies and in vivo preclinical oncology models to investigate therapeutic efficacy.
Product Specifications
Product Name Alternative
ABBV 181, ABBV181, PR 1648817, PR1648817
Target
PD-1/PD-L1
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
5.22 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
145.72 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog